Peds
Fever Without Focus Management 3 to 36 months
search
Fever Without Focus Management 3 to 36 months
, Fever Without Focus Management 2 to 24 months
See Also
Fever Without Focus
Toxic Findings Suggestive of Occult Bacteremia
Fever Without Focus Labs
Fever Without Focus Management Birth to 3 Months
Pediatric Sepsis
Neonatal Sepsis
Rochester Criteria for Febrile Infant 0 to 60 days
Philadelphia Criteria for Febrile Infant 29-60 days
Milwaukee Criteria for Febrile Infant 28-56 days
Boston Criteria for Febrile Infant 28-89 days
Yale Scale for Febrile Child 3 to 36 months
Indications
Previously well child
Febrile child 3 to 36 months (Guidelines are shifting toward 2 to 24 months)
No obvious source of fever
History
Immunization
Effects on
Occult Bacteremia
Incidence
Haemophilus
Influenza
e Type B
Vaccine
(
Hib Vaccine
) introduced in U.S. 1985
Occult Bacteremia
Incidence
with high fever dropped from 3-9% to 2-3%
Primary cause of
Occult Bacteremia
changed to
Streptococcus Pneumoniae
Pneumococcal Conjugate Vaccine
(Prenar 7) introduced in U.S. 2000
Occult Bacteremia
Incidence
with high fever dropped from 2-3% to <0.5%
Pneumococcal Conjugate Vaccine
(Prenar 13) introduced in U.S. 2010
Invasive pneumococcal disease dropped more than 50% (21.9 to 9.3 per 100,000)
Approach
Triage
Toxic appearing febrile child
See
Yale Observation Scale
See
Toxic Findings Suggestive of Occult Bacteremia
Admit to hospital
Full rule-out
Sepsis
workup
See
Fever Without Focus Labs
Parenteral
Antibiotic
s
See
Antibiotic
selection in Step 5 below
Non-toxic child with fever <39.0 C (<102.2 F)
Up to 50% of children with serious
Bacterial Infection
appear well
Avoid further diagnostic tests or
Antibiotic
s unless otherwise indicated
Fever Symptomatic Treatment
Careful examination to rule out serious infection
Urinary Tract Infection
(most common)
Pneumonia
(common)
Abscess
Cellulitis
or
Impetigo
Acute Sinusitis
Otitis Media
Osteomyelitis
Lymphadenitis
Streptococcal Pharyngitis
or
Scarlet Fever
Re-evaluation criteria
Fever
persists longer than 48 hours
Condition deteriorates
Consider
Urinalysis
and
Urine Culture
Girls age <12 months
Boys age <6 months (or <12 months if uncircumcised)
High fever (>39 C or 102 F)
Persistent fever >24 hours
Non-toxic child with fever >38.9 C (>102.1 F)
See protocol below
Diagnosis
Predictors of
Occult Bacteremia
for ages 3-36 months
See
Toxic Findings Suggestive of Occult Bacteremia
Precautions
Unimmunized and underimmunized children bring back concerns from a pre-Hib era
Pre-Hib Era:
Fever
in non-toxic child ages 3-36 months
Temperature
<39.5 C (103.1 F): 1.6% Positive
Blood Culture
Temperature
<34.0 C (93.2 F): 2.1% Positive
Blood Culture
Temperature
<41.0 C (105.8 F): 3.5% Positive
Blood Culture
Temperature
>41.0 C (105.8 F): 9.3% Positive
Blood Culture
Post-Hib Era:
Fever
in non-toxic child ages 3-36 months
Temperature
<39.5 C (103.1 F): 0.9% Positive
Blood Culture
Temperature
<34.0 C (93.2 F): 1.1% Positive
Blood Culture
Temperature
<40.5 C (104.9 F): 1.7% Positive
Blood Culture
Temperature
<41.0 C (105.8 F): 2.4% Positive
Blood Culture
Temperature
>41.0 C (105.8 F): 2.8% Positive
Blood Culture
Post-Hib Era: WBC in non-toxic child ages 3-36 months
WBC <5k C: 0.0% Positive
Blood Culture
WBC <10k C: 0.1% Positive
Blood Culture
WBC <15k C: 0.5% Positive
Blood Culture
WBC <20k C: 3.5% Positive
Blood Culture
WBC <25k C: 6.8% Positive
Blood Culture
WBC <30k C: 7.2% Positive
Blood Culture
WBC >30k C: 18.3% Positive
Blood Culture
Evaluation
Step 1 - Evaluate
Fever
by
Rectal Temperature
Fever
with
Rectal Temperature
<102.2 F (39 C)
Observe without testing (or consider
Urinalysis
)
Follow-up if worsening or >48 hours of fever
Fever
with
Rectal Temperature
>102.2 F (39 C)
Go to Step 2 unless criteria below met
Consider
Urinalysis
(esp fever>2 days without source)
Girls age <12 months
Boys age <6 months (or <12 months if uncircumcised)
Criteria for observation without labs,
Antibiotic
s
See
Toxic Findings Suggestive of Occult Bacteremia
Non-toxic appearance
Immunization
s up-to-date
Follow-up within 24-48 hours
Evaluation
Step 2 - Obtain Initial Labs
Labs
Complete Blood Count
with differential
Urinalysis
with
Urine Culture
Indicated in under 24 months or findings suggestive of UTI in 24-36 month old children
False Negative
Urinalysis
in 30% of children with positive
Urine Culture
Do not obtain bag urine (
False Positive Rate
85%)
May defer in a well appearing infant over age 3 months
Must have close follow-up within 2-3 days
Child is likely to have localizing symptoms by 2-3 days
Informed Consent
with parents
Risk of initially missed
Pyelonephritis
vs urine catheterization
Sacchetti and Newman in Majoewsky (2013) EM:Rap 13(5): 4-5
Protocol
Consider
Chest XRay
(see step 4) as indicated
Go to step 3 unless criteria below are met
Criteria for low-risk observation (24 hour follow-up)
See
Toxic Findings Suggestive of Occult Bacteremia
White Blood Cell Count
<15,000
Absolute Neutrophil Count
<10,000
Urinalysis
normal
Evaluation
Step 3 - Obtain Cultures
See
Fever Without Focus Labs
Urine Culture
Obtain in all cases in which
Urinalysis
is ordered
Urinalysis
alone is insufficient
Blood Culture
All cases in which labs abnormal above
Obtain if
Antibiotic
s are given
Cerebrospinal fluid (CSF) by
Lumbar Puncture
Indicated if neurologic or meningeal signs present in ill appearing children
Not required if no meningeal and neurologic signs
Should be a non-toxic appearing child over age 3 months
Should have a normal
White Blood Cell Count
Evaluation
Step 4 - Additional Studies
Chest XRay
Indications
Oxygen Saturation
(
O2 Sat
) <95%
Respiratory distress
Tachypnea
or
Tachycardia
out of proportion to fever
Expect
Heart Rate
to increase 10 bpm for every increase in
Temperature
of 1 C
Rales on lung auscultation
Fever
over 39.0 to 39.5 C (102.2 to 103.1 F) or higher
Asymptomatic with
White Blood Cell Count
>20,000
Stool Culture
Indications
Diarrhea
Findings on stool exam that increase likelihood of
Bacterial Infection
Stool
blood or mucus present
Fecal Leukocytes
> 5 WBCs per high powered field
Evaluation
Step 5 - Consider
Antibiotic
s (fever >39 C)
Decision to use
Antibiotic
s empirically
Ill appearing young children with high fever should be treated and admitted
See
Toxic Findings Suggestive of Occult Bacteremia
See approach to triage above
Unimmunized or Underimmunized children and age <2 years (24 months)
Consider
Antibiotic
s for
White Blood Cell Count
>15,000/uL
Close interval follow-up without
Antibiotic
s is a reasonable approach
Indicated in non-toxic appearing children
Decision to start empiric
Antibiotic
s is one of clinical judgement
Based on likelihood of serious underlying occult infection
Gene
ral empiric coverage
Ceftriaxone
(
Rocephin
) 50 mg/kg/day (max: 1 g)
Suspected urinary tract source
Cefotaxime
(
Claforan
) 50 mg/kg IV every 8 hours or
Cefixime
(
Suprax
) 8 mg/kg twice daily for day one, then 8 mg/kg daily
Suspected
Pneumonia
Amoxicillin
80 mg/kg/day divided every 8-12 hours or
Azithromycin
10 mg/kg orally on day 1, then 5 mg/kg on days 2-5
Alternative if
Penicillin
allergic
If
Antibiotic
s are given, then:
Obtain all cultures that are indicated in Step 3
Re-evaluate within 24 hours
Step 4
Disposition
Admit patients with unreliable follow-up
Follow-up
Return within 24 hours if
Antibiotic
s started
Return in 48 hours indication
Fever
persists
Condition deteriorates
Home management
Observe for toxic appearance
Fever Symptomatic Treatment
Step 5
Blood Culture
or
Urine Culture
positive
Admit if child febrile or toxic appearance
Outpatient
Antibiotic
s if afebrile and well-appearing
References
Caskey and Ponce (2018) Crit Dec Emerg Med 32(11): 12-3
Claudius, Seiden and Sacchetti in Swadron (2023) EM:Rap 23(1): 11-2
Herman (2015) Crit Dec Emerg Med 29(12):14-19
(1993) Ann Emerg Med 22(3):628-37 [PubMed]
Baraff (2000) Ann Emerg Med 36:602-14 [PubMed]
Baraff (1993) Pediatrics 92(1): 1-12 [PubMed]
Daaleman (1996) Am Fam Physician 54(8):2503 [PubMed]
Hamilton (2013) Am Fam Physician 87(4): 254-60 [PubMed]
Kimmel (1996) Fam Pract Recert 18(7):69-85 [PubMed]
Luszczak (2001) Am Fam Physician 64(7):1219-26 [PubMed]
Lopez (1997) Postgrad Med 101(2):241-52 [PubMed]
Sur (2007) Am Fam Physician 75:1805-11 [PubMed]
Type your search phrase here